Cargando…
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816412/ https://www.ncbi.nlm.nih.gov/pubmed/31692823 http://dx.doi.org/10.1080/23723556.2019.1650631 |
| _version_ | 1783463366009815040 |
|---|---|
| author | Horibata, Sachi |
| author_facet | Horibata, Sachi |
| author_sort | Horibata, Sachi |
| collection | PubMed |
| description | We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies. |
| format | Online Article Text |
| id | pubmed-6816412 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68164122020-08-28 Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients Horibata, Sachi Mol Cell Oncol Author’s Views We recently identified three sub-populations of refractory acute myeloid leukemia (AML) patients with distinct intrinsic resistance mechanisms. Furthermore, we were able to risk-stratify the overall survival of the patients and identify patients who would likely benefit from alternative therapies. Taylor & Francis 2019-08-28 /pmc/articles/PMC6816412/ /pubmed/31692823 http://dx.doi.org/10.1080/23723556.2019.1650631 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
| spellingShingle | Author’s Views Horibata, Sachi Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_full | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_fullStr | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_full_unstemmed | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_short | Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| title_sort | transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients |
| topic | Author’s Views |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816412/ https://www.ncbi.nlm.nih.gov/pubmed/31692823 http://dx.doi.org/10.1080/23723556.2019.1650631 |
| work_keys_str_mv | AT horibatasachi transcriptomicprofileofintrinsicallychemoresistantacutemyeloidleukemiapatients |